Themis Medicare declined 2.06% to Rs 145.05 at 13:38 IST on BSE, after a fire and explosion took place in one of the sections of the company's Vapi factory on Friday, 13 November 2009.
The company made this announcement during trading hours today, 16 November 2009.
Meanwhile, the BSE Sensex was up 207.51 points, or 1.23%, to 17,056.34.
On BSE, 1,469 shares were traded in the counter as against an average daily volume of 3,948 shares in the past one quarter.
The stock hit a high of Rs 149 and a low of Rs 149 so far during the day. The stock had hit a 52-week high of Rs 164.80 on 5 November 2009 and a 52-week low of Rs 49 on 6 March 2009.
The small-cap stock had outperformed the market over the past one month till 13 November 2009, rising 21% as compared to the Sensex's 1.04% fall. It had also outperformed the market in the past one quarter, gaining 44.07% as compared to the Sensex's return of 8.57%.
The company's equity capital is Rs 8.05 crore. Face value per share is Rs 10.
The current price of Rs 145.05 discounts the company's Q2 September 2009 annualized EPS of Rs 47.20 by a PE multiple of 3.07.
The company is fully insured and steps are being taken to restore normalcy at the exploded section of the plant. The other plants are in operation, the company said.
Themis Medicare's net profit galloped 787.9% 9.50 crore on 10.9% rise in net sales to Rs 60.98 crore in Q2 September 2009 over Q2 September 2008.
The company is engaged in manufacturing and selling pharmaceutical products. The group's products are used in therapeutic areas like antituberculosis, antimalarials, cardiology, pain management, anti-infectives, haematinics, Health and Nutrition. It also engaged in co-marketing its research-based formulations with other pharmaceutical companies in India and abroad.
Source: indiainfoline.com
Pharmaceutical Process Equipment
